CISTIM is a small molecule drug discovery center founded in 2007. Operating as a drug discovery centre, they work on driving the translation of innovative basic research to the clinic. In collaboration with @CD3 - Centre for Drug Design and Discovery, CISTIM conducts research projects focused on the validation of innovative biomedical concepts, biological research to identify new small molecules and biologicals, as well as chemical synthesis and biological evaluation of molecules and biologicals to optimize their biological activity from hit to lead. The company operates in the Biotechnology, Industrial, Life Sciences industries and is based in Leuven vzw. Currently, there is no information available about their last investment or investors. This indicates that the company might be operating without external funding. With a focus on translating basic research into clinical applications, CISTIM plays a pivotal role in the development of new drugs and therapies.
There is no investment information
No recent news or press coverage available for CISTIM.